SCHEMBL5032007

SCHEMBL5032007

Cn1ccnc1CCCO

nearest known ligand 0.46

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
FNTA P49354 1/20 0.40
FNTB P49356 1/20 0.40
OPRK1 P41145 1/20 0.39
LPO P22079 1/20 0.39
CNR2 P34972 1/20 0.36
DRD4 P21917 1/20 0.35
TLR7 Q9NYK1 2/20 0.35
NAMPT P43490 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2939806 0.98 FDPS (0.44) FDPSMEN1KMT2AFNTAFNTB
Bromide SCHEMBL18941396 0.98 FDPS (0.44) FDPSMEN1KMT2AFNTAFNTB
SCHEMBL12471754 0.94 FDPS (0.44) FDPSMEN1KMT2AFNTAFNTB
SCHEMBL16700474 0.92 FDPS (0.42) FDPSMEN1KMT2AFNTAFNTB
SCHEMBL30071648 0.92 FDPS (0.42) FDPSMEN1KMT2AFNTAFNTB
Sulfuric Acid SCHEMBL15820306 0.91 FDPS (0.43) FDPSMEN1KMT2AFNTAFNTB
Acetic Acid SCHEMBL2943155 0.91 FNTA (0.47) FDPSMEN1KMT2AFNTAFNTB
SCHEMBL16699808 0.90 FDPS (0.42) FDPSMEN1KMT2AFNTAFNTB
SCHEMBL2418078 0.88
SCHEMBL7166348 0.87 FDPS (0.46) FDPSMEN1KMT2AFNTAFNTB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025128828-A1 METHODS OF SOLVENT DISPLACEMENT FOR METAL-CONTAINING IONIC LIQUIDS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2025-06-19 WO claimed
US-20250196021-A1 METHODS OF SOLVENT DISPLACEMENT FOR METAL-CONTAINING IONIC LIQUIDS CHEVRON PHILLIPS CHEMICAL COMPANY LP 2025-06-19 US claimed
CN-107427758-B Separation using ionic liquid solvents 切弗朗菲利浦化学公司 2020-11-20 CN claimed
US-10227274-B2 Separations with ionic liquid solvents CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2019-03-12 US claimed
EP-3244987-A1 SEPARATIONS WITH IONIC LIQUID SOLVENTS Chevron Phillips Chemical Company LP (US) 2017-11-22 EP claimed
US-20150133711-A1 Separations With Ionic Liquid Solvents CHEVRON PHILLIPS CHEMICAL COMPANY LP 2015-05-14 US claimed
US-20260015304-A1 METAL-CONTAINING IONIC LIQUIDS WITH REDUCED VISCOSITY CHEVRON PHILLIPS CHEMICAL CO LP (US) 2026-01-15 US disclosed
US-12441671-B2 Metal-containing ionic liquids with reduced viscosity CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2025-10-14 US disclosed
EP-4396183-B1 SUBSTITUTED S-ALANINATE DERIVATIVES BAYER AG (DE) 2025-09-03 EP disclosed
US-12365647-B2 Method for preparing acrylonitrile dimer LG CHEM, LTD. (KR) 2025-07-22 US disclosed
WO-2025128828-A1 METHODS OF SOLVENT DISPLACEMENT FOR METAL-CONTAINING IONIC LIQUIDS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2025-06-19 WO disclosed
US-20250196021-A1 METHODS OF SOLVENT DISPLACEMENT FOR METAL-CONTAINING IONIC LIQUIDS CHEVRON PHILLIPS CHEMICAL COMPANY LP 2025-06-19 US disclosed
EP-3507346-B1 ALKYLATION OF REFINERY PENTENES WITH ISOBUTANE CHEVRON USA INC (US) 2025-04-30 EP disclosed
US-20150133711-A1 Separations With Ionic Liquid Solvents CHEVRON PHILLIPS CHEMICAL COMPANY LP 2015-05-14 US disclosed
US-20080191170-A1 Use of Ionic Liquids CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED (GB) 2008-08-14 US disclosed
EP-1804969-A2 USE OF IONIC LIQUIDS CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED (GB) 2007-07-11 EP disclosed
WO-2006038013-A2 USE OF IONIC LIQUIDS CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED (GB) 2006-04-13 WO disclosed
CN-1060173-C Heterocyclic compound with activity against diabetes and preparation and application of same MITSUTAKA CO LTD (JP) 2001-01-03 CN disclosed
CN-1118781-A Heterocyclic compound with activity against diabetes and preparation and application of same MITSUTAKA CO LTD (JP) 1996-03-20 CN disclosed
EP-0510036-B1 2-SUBSTITUTED 4,5-DIPHENYL-IMIDAZOLES RHONE POULENC RORER SA (FR) 1995-04-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12365647-B2 Method for preparing acrylonitrile dimer ADH1C, ADH1A, PUF60 FDPS 922/4885MEN1 1928/4885KMT2A 4707/4885
US-20260015304-A1 METAL-CONTAINING IONIC LIQUIDS WITH REDUCED VISCOSITY EXOC3, ELL, IGF2BP2 FDPS 4457/4885MEN1 2342/4885KMT2A 3292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.